Julie Batista

Research Associate

Department of Epidemiology

Department of Epidemiology

Channing Division of Network Medicine
181 Longwood Avenue, 3rd Floor
Boston, Massachusetts 02115
Phone: 617.525.2242
Fax: 617.525.2008

née: Kasperzyk


Boston College, Chestnut Hill, MA B.S. 2001 Biochemistry
Harvard School of Public Health, Boston, MA Sc.M. 2006 Epidemiology
Harvard School of Public Health, Boston, MA Sc.D. 2009 Epidemiology


I am an Instructor in the Channing Division of Network Medicine at HMS/BWH and a Research Associate at HSPH. My work focuses on nutrition, lifestyle factors, and molecular biomarkers that influence prostate cancer risk and development of metastatic disease. My research skills include epidemiologic study design, questionnaire development, statistical methods, and large-scale data analyses.


Lorelei Mucci, ScD & Meir Stampfer, MD, DrPH

Selected Publications

  • Chang ET, Birmann BM, Kasperzyk JL, Conti DV, Kraft P, Ambinder RF, Zheng T, Mueller NE. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2009;18:976-86. PMCID: PMC2720066
  • Kasperzyk JL, Fall K, Mucci LA, Håkansson N, Wolk A, Johansson J-E, Andersson S-O, Andrén O. One-carbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr 2009;90:561-9. PMCID: PMC2728642
  • Shappley III WV, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan JM. A prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. J Clin Oncol 2009;27:4980-5. PMCID: PMC2799054
  • Epstein MM, Kasperzyk JL, Andrén O, Giovannucci EL, Wolk A, Håkansson N,  Andersson SO, Johansson JE, Fall K, Mucci LA Dietary zinc and prostate cancer survival in a Swedish cohort. Am J Clin Nutr 2011;93:586-93. PMCID: PMC3041600
  • Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney K, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci EL. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol 2011;29:2378-85. PMCID: PMC3107752
  • Wilson KM, Kasperzyk JL, Stark JR, Kenfield, S, van Dam RM, Stampfer MJ, Giovannucci EL, Mucci LA. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 2011;103:876-84. PMCID: PMC3110172
  • Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One 2011;6:e18625. PMCID: PMC3071841
  • Kasperzyk JL, Chang ET, Birmann ET, Kraft P, Zheng T, Mueller NE. Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study. Am J Epidemiology 2011;174:816-27. PMCID: PMC3203380
  • Kasperzyk JL, Shappley III WV, Kenfield SA, Mucci LA, Kurth T, Ma J, Stampfer MJ, Sanda MG. Watchful waiting and quality of life among prostate cancer survivors in the Physicians’ Health Study. J Urol  2011; 186:1862-7. PMCID: PMC3491639
  • Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, Stampfer MJ, Mucci LA. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians’ Health Study. Int J Radiat Oncol Biol Phys 2012;83:28-32. PMCID: PMC3386602
  • Torfadóttir JE, Steingrímsdóttir L, Mucci L, Aspelund T, Kasperzyk JL, Ólafsson Ö, Fall K, Tryggvadóttir L, Harris TB, Launer L, Jónsson E, Tulinius H, Stampfer M, Adami HO, Guđnason V, Valdimarsdóttir UA. Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiology 2012;175:144-53. PMCID: PMC3249408
  • PetterssonA, Kasperzyk JL, Kenfield SA, Richman EL, Chan JM, Willett WC, Stampfer MJ, Mucci LA, Giovannucci EL. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev 2012;21:428-36. PMCID: PMC3297731
  • Torfadóttir JE, Valdimarsdóttir UA, Mucci L, Stampfer M, Kasperzyk JL, Fall K, Tryggvadóttir L, Aspelund T, Ólafsson Ö, Harris TB, Jónsson E, Tulinius H, Adami HO, Guđnason V, Steingrímsdóttir L. Rye bread consumption in early life and reduced risk of advanced prostate cancer. Cancer Causes Control 2012;23:941-50. PMCID: PMC3568695
  • Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue. Cancer Causes Control 2012;23:1359-66. PMCID: PMC3589913
  • Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci EL, Price A, Wolk A, Håkansson N, Andersson S-O, Johansson J-E, Fall K, Andrén O. Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden. Am J Epidemiology 2012;176:240-52. PMCID: PMC3491963
  • Schoenfeld JD, Margalit DN, KasperzykJL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci E, Stampfer MJ, Mucci LA. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res 2013;19:1612-9. PMCID: PMC3602407
  • Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami H-O, Stampfer M, Steingrimsdottir L. Consumption of fish products across the lifespan and prostate cancer risk. PLoS One 2013;8:e59799. PMCID: PMC3629172
  • Russnes KMWilson KMEpstein MMKasperzyk JLStampfer MJKenfield SASmeland SBlomhoff RGiovannucci ELWillett WCMucci LA. Total antioxidant intake in relation to prostate cancer incidence in the health professionals follow up study. Int J Cancer 2014;134:1156-65. PMCID: in process
  • Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA. Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev 2013;22:2354-63. PMCID: PMC389363
  • Preston MA, Riis AH, Ehrenstein V, Breau RH, Batista JL, Olumi AF, Mucci LA, Adami HO, Sorensen HT. Metformin use and prostate cancer risk. European Urology 2014 [in press]